FDA's "Act Now" Philosophy Has Drawbacks For Industry - CHPA Exec
This article was originally published in The Tan Sheet
Executive Summary
FDA's current speed in taking action sometimes sacrifices fair treatment of industry and can fail to allow for logistical realities, according to OTC stakeholders